Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Surgical Oncology
Cancer Prevention
Questions discussed in this category
When do you recommend endocrine therapy for chemoprevention in women with high-risk benign breast lesions?
1 Answer available
3723
Papers discussed in this category
NPJ breast cancer, 2016
Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.
Related Topics in Surgical Oncology
Breast Cancer
Medical Oncology
Radiation Oncology
Breast Surgery
NCI-CCC Tumor Board Question
Breast Cancer, Non-metastatic
University of Wisconsin
NCI-CCC Breast Tumor Board Question
Genitourinary Cancers
MD Anderson